We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.95B
AUM Growth
-$232M
Cap. Flow
-$467M
Cap. Flow %
-9.44%
Top 10 Hldgs %
11.79%
Holding
1,100
New
153
Increased
294
Reduced
399
Closed
191

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$28.6M
2
INTU icon
Intuit
INTU
+$27.6M
3
EA icon
Electronic Arts
EA
+$23.2M
4
QCOM icon
Qualcomm
QCOM
+$22.5M
5
CVX icon
Chevron
CVX
+$19.1M

Sector Composition

Rank Sector Weight
1 Technology 20.09%
2 Financials 17.69%
3 Healthcare 13.21%
4 Industrials 12.31%
5 Consumer Discretionary 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVUS
801
DELISTED
Vivus Inc
VVUS
$199K ﹤0.01%
17,780
+7,790
+78% +$88.2K
QNST icon
802
QuinStreet
QNST
$870M
$198K ﹤0.01%
50,862
-16,843
-25% -$59.2K
LEAF
803
DELISTED
Leaf Group Ltd.
LEAF
$196K ﹤0.01%
26,136
EYPT icon
804
EyePoint Inc
EYPT
$1.02B
$195K ﹤0.01%
+11,347
New +$202K
OMED
805
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$193K ﹤0.01%
+21,000
New +$184K
HALL
806
DELISTED
Hallmark Financial Services, Inc.
HALL
$186K ﹤0.01%
1,687
-71
-4% -$7.88K
CDXS icon
807
Codexis
CDXS
$135M
$185K ﹤0.01%
38,510
+16,010
+71% +$73K
AGTC
808
DELISTED
Applied Genetic Technologies Corporation
AGTC
$185K ﹤0.01%
26,800
+400
+2% +$3.13K
VOLT
809
DELISTED
Volt Information Sciences, Inc.
VOLT
$180K ﹤0.01%
+26,048
New +$196K
TLRA
810
DELISTED
Telaria, Inc.
TLRA
$176K ﹤0.01%
88,005
-8,455
-9% -$19K
WEN icon
811
Wendy's
WEN
$1.33B
$173K ﹤0.01%
+12,700
New +$173K
EGIO
812
DELISTED
Edgio, Inc. Common Stock
EGIO
$172K ﹤0.01%
1,669
-1,828
-52% -$171K
WMAR
813
DELISTED
West Marine Inc
WMAR
$171K ﹤0.01%
17,900
AAMI
814
Acadian Asset Management
AAMI
$2.88B
$168K ﹤0.01%
+11,100
New +$164K
GLOG
815
DELISTED
GASLOG LTD
GLOG
$166K ﹤0.01%
+10,800
New +$173K
VYNT
816
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$165K ﹤0.01%
268
-508
-65% -$181K
ACET
817
DELISTED
Aceto Corp
ACET
$162K ﹤0.01%
+10,235
New +$175K
HBIO icon
818
Harvard Bioscience
HBIO
$27.1M
$160K ﹤0.01%
6,147
+716
+13% +$20.6K
KIN
819
DELISTED
Kindred Biosciences, Inc.
KIN
$160K ﹤0.01%
22,663
-9,600
-30% -$60.1K
STML
820
DELISTED
Stemline Therapeutics, Inc.
STML
$160K ﹤0.01%
18,700
-6,254
-25% -$57K
CVO
821
DELISTED
Cenevo, Inc.
CVO
$160K ﹤0.01%
31,887
-15,761
-33% -$97.7K
RGS icon
822
Regis Corp
RGS
$69.9M
$158K ﹤0.01%
675
-2,694
-80% -$702K
PCTI
823
DELISTED
PCTEL, Inc. Common Stock
PCTI
$157K ﹤0.01%
22,087
-430
-2% -$2.45K
GPK icon
824
Graphic Packaging
GPK
$3.26B
$154K ﹤0.01%
12,000
NVTR
825
DELISTED
Nuvectra Corporation Common Stock
NVTR
$152K ﹤0.01%
+22,200
New +$152K

Similar funds

Jacobs Levy Equity Management's Q1 2017 Portfolio in Review

As of Q1 2017, Jacobs Levy Equity Management held 1,100 positions worth $4.95B, down 4.5% from $5.18B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $467M in Q1 2017, closing 191 positions and reducing 399 holdings. Its most notable exit was VMware, Inc, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Intuit worth $26.7M.

  • Jacobs Levy Equity Management's largest Q1 2017 buy was Intuit: 229,923 shares worth $26.7M.
  • Jacobs Levy Equity Management added most to Celgene Corp in Q1 2017, an estimated $28.6M increase.
  • Jacobs Levy Equity Management's biggest Q1 2017 reduction was Amgen, cutting an estimated $41.2M.
  • Jacobs Levy Equity Management fully exited VMware, Inc in Q1 2017, selling an estimated $22.6M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $4.95B portfolio in Q1 2017.
  • Jacobs Levy Equity Management opened 153 new positions and closed 191 in Q1 2017.
  • Jacobs Levy Equity Management's portfolio value fell 4.5% quarter-over-quarter to $4.95B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.